non compound tirzepatide FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now hormone GLP Compounded Tirzepatide for Women |

Retatrutides ~144-hour half-life and tirzepatides ~120-hour half-life both support a single weekly subcutaneous dose, the schedule used in every registrational trial

You may qualify for GLP-1 weight loss treatment if: Your BMI is 27+ with weight-related health concerns Youve tried traditional diets without long-term success Youre not pregnant, breastfeeding, or planning pregnancy You have no history of certain thyroid or endocrine conditions At Genesis MedSpa, patients undergo a full health assessment, lab review, and consultation before starting any medication-based program

7:e48924

These options offer powerful outcomes that can change lives